Given the involvement of the SHANK pathway in tumorigenesis, we comprehensively evaluated the associations of 161 SNPs among SHANK family genes with the risk of RCC and survival in a cohort of 630 patients with RCC and controls from Taiwan. The gene discussed is SHANK2; the disease is renal cell carcinoma.